355 related articles for article (PubMed ID: 23994138)
21.
Ok T; Jung YH; Kim J; Park SK; Park G; Lee S; Lee KY
J Am Heart Assoc; 2022 Aug; 11(15):e025676. PubMed ID: 35876407
[TBL] [Abstract][Full Text] [Related]
22. Genetic analysis of RNF213 p.R4810K variant in non-moyamoya intracranial artery stenosis/occlusion disease in a Chinese population.
Zhang T; Guo C; Liao X; Xia J; Wang X; Deng J; Yan J
Environ Health Prev Med; 2017 Apr; 22(1):41. PubMed ID: 29165136
[TBL] [Abstract][Full Text] [Related]
23. Identification of RNF213 as a susceptibility gene for moyamoya disease and its possible role in vascular development.
Liu W; Morito D; Takashima S; Mineharu Y; Kobayashi H; Hitomi T; Hashikata H; Matsuura N; Yamazaki S; Toyoda A; Kikuta K; Takagi Y; Harada KH; Fujiyama A; Herzig R; Krischek B; Zou L; Kim JE; Kitakaze M; Miyamoto S; Nagata K; Hashimoto N; Koizumi A
PLoS One; 2011; 6(7):e22542. PubMed ID: 21799892
[TBL] [Abstract][Full Text] [Related]
24. Genotype-Phenotype Correlation in Long-Term Cohort of Japanese Patients with Moyamoya Disease.
Nomura S; Yamaguchi K; Akagawa H; Kawashima A; Moteki Y; Ishikawa T; Aihara Y; Saito T; Okada Y; Kawamata T
Cerebrovasc Dis; 2019; 47(3-4):105-111. PubMed ID: 30947170
[TBL] [Abstract][Full Text] [Related]
25. Can Moyamoya Disease Susceptibility Gene Affect Extracranial Systemic Artery Stenosis?
Nomura S; Aihara Y; Akagawa H; Chiba K; Yamaguchi K; Kawashima A; Okada Y; Kawamata T
J Stroke Cerebrovasc Dis; 2020 Feb; 29(2):104532. PubMed ID: 31806452
[TBL] [Abstract][Full Text] [Related]
26. Renovascular hypertension and
Kim JY; Cho H
Clin Nephrol; 2021 Aug; 96(2):105-111. PubMed ID: 33769276
[TBL] [Abstract][Full Text] [Related]
27. Temporal profile of magnetic resonance angiography and decreased ratio of regulatory T cells after immunological adjuvant administration to mice lacking RNF213, a susceptibility gene for moyamoya disease.
Kanoke A; Fujimura M; Niizuma K; Fujimura T; Kakizaki A; Ito A; Sakata H; Sato-Maeda M; Kure S; Tominaga T
Brain Res; 2016 Jul; 1642():1-9. PubMed ID: 26972532
[TBL] [Abstract][Full Text] [Related]
28. Role of the
Kim HJ; Choi EH; Chung JW; Kim JH; Kim YS; Seo WK; Kim GM; Bang OY
J Am Heart Assoc; 2021 Jan; 10(1):e017660. PubMed ID: 33356381
[TBL] [Abstract][Full Text] [Related]
29. RNF213 rare variants in an ethnically diverse population with Moyamoya disease.
Cecchi AC; Guo D; Ren Z; Flynn K; Santos-Cortez RL; Leal SM; Wang GT; Regalado ES; Steinberg GK; Shendure J; Bamshad MJ; ; Grotta JC; Nickerson DA; Pannu H; Milewicz DM
Stroke; 2014 Nov; 45(11):3200-7. PubMed ID: 25278557
[TBL] [Abstract][Full Text] [Related]
30. Meta-analysis of genotype and phenotype studies to confirm the predictive role of the RNF213 p.R4810K variant for moyamoya disease.
Wang Y; Yang L; Wang X; Zeng F; Zhang K; Zhang Q; Liu M; Liu S; Shang M; Li Q; Yang Y; Liang M; Liu W
Eur J Neurol; 2021 Mar; 28(3):823-836. PubMed ID: 33175469
[TBL] [Abstract][Full Text] [Related]
31. An analysis of the demographic history of the risk allele R4810K in RNF213 of moyamoya disease.
Koganebuchi K; Sato K; Fujii K; Kumabe T; Haneji K; Toma T; Ishida H; Joh K; Soejima H; Mano S; Ogawa M; Oota H
Ann Hum Genet; 2021 Sep; 85(5):166-177. PubMed ID: 34013582
[TBL] [Abstract][Full Text] [Related]
32. Genetic Analysis of RNF213 c.14576G>A Variant in Nonatherosclerotic Quasi-Moyamoya Disease.
Miyawaki S; Imai H; Shimizu M; Yagi S; Ono H; Nakatomi H; Shimizu T; Saito N
J Stroke Cerebrovasc Dis; 2015 May; 24(5):1075-9. PubMed ID: 25817623
[TBL] [Abstract][Full Text] [Related]
33. P.R4810K, a polymorphism of RNF213, the susceptibility gene for moyamoya disease, is associated with blood pressure.
Koizumi A; Kobayashi H; Liu W; Fujii Y; Senevirathna ST; Nanayakkara S; Okuda H; Hitomi T; Harada KH; Takenaka K; Watanabe T; Shimbo S
Environ Health Prev Med; 2013 Mar; 18(2):121-9. PubMed ID: 22878964
[TBL] [Abstract][Full Text] [Related]
34. Homozygous c.14576G>A variant of RNF213 predicts early-onset and severe form of moyamoya disease.
Miyatake S; Miyake N; Touho H; Nishimura-Tadaki A; Kondo Y; Okada I; Tsurusaki Y; Doi H; Sakai H; Saitsu H; Shimojima K; Yamamoto T; Higurashi M; Kawahara N; Kawauchi H; Nagasaka K; Okamoto N; Mori T; Koyano S; Kuroiwa Y; Taguri M; Morita S; Matsubara Y; Kure S; Matsumoto N
Neurology; 2012 Mar; 78(11):803-10. PubMed ID: 22377813
[TBL] [Abstract][Full Text] [Related]
35. Predictive role of heterozygous p.R4810K of
Wang Y; Zhang Z; Wei L; Zhang Q; Zou Z; Yang L; Li D; Shang M; Han C; Mambiya M; Bao X; Li Q; Hao F; Zhang K; Wang H; Liu S; Liu M; Zeng F; Nie F; Wang K; Liu W; Duan L
Neurology; 2020 Feb; 94(7):e678-e686. PubMed ID: 31949090
[TBL] [Abstract][Full Text] [Related]
36. Moyamoya disease susceptibility gene RNF213 links inflammatory and angiogenic signals in endothelial cells.
Ohkubo K; Sakai Y; Inoue H; Akamine S; Ishizaki Y; Matsushita Y; Sanefuji M; Torisu H; Ihara K; Sardiello M; Hara T
Sci Rep; 2015 Aug; 5():13191. PubMed ID: 26278786
[TBL] [Abstract][Full Text] [Related]
37. RNF213 polymorphism and Moyamoya disease: A systematic review and meta-analysis.
Ma J; Liu Y; Ma L; Huang S; Li H; You C
Neurol India; 2013; 61(1):35-9. PubMed ID: 23466837
[TBL] [Abstract][Full Text] [Related]
38. Association between the rs112735431 polymorphism of the RNF213 gene and moyamoya disease: A case-control study and meta-analysis.
Huang Y; Cheng D; Zhang J; Zhao W
J Clin Neurosci; 2016 Oct; 32():14-8. PubMed ID: 27515544
[TBL] [Abstract][Full Text] [Related]
39. Impacts and interactions of PDGFRB, MMP-3, TIMP-2, and RNF213 polymorphisms on the risk of Moyamoya disease in Han Chinese human subjects.
Wang X; Zhang Z; Liu W; Xiong Y; Sun W; Huang X; Jiang Y; Ni G; Sun W; Zhou L; Wu L; Zhu W; Li H; Liu X; Xu G
Gene; 2013 Sep; 526(2):437-42. PubMed ID: 23769926
[TBL] [Abstract][Full Text] [Related]
40. Moyamoya Disease and Spectrums of RNF213 Vasculopathy.
Bang OY; Chung JW; Kim DH; Won HH; Yeon JY; Ki CS; Shin HJ; Kim JS; Hong SC; Kim DK; Koizumi A
Transl Stroke Res; 2020 Aug; 11(4):580-589. PubMed ID: 31650369
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
